David William Ball
Director/Board Member at ALLERGY THERAPEUTICS PLC
David William Ball active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALLERGY THERAPEUTICS PLC | Director/Board Member | 26/06/2024 | - |
| Independent Dir/Board Member | 26/06/2024 | - | |
Argonaute RNA Ltd.
 Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021. | Director/Board Member | - | - |
Career history of David William Ball
Former positions of David William Ball
| Companies | Position | Start | End |
|---|---|---|---|
Brainomix Ltd.
 Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - | - |
Training of David William Ball
| University of Cambridge | Graduate Degree |
Statistics
International
| United Kingdom | 5 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALLERGY THERAPEUTICS PLC | Health Technology |
| Private companies | 2 |
|---|---|
Brainomix Ltd.
Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021. | Commercial Services |
- Stock Market
- Insiders
- David William Ball
- Experience
